Sens. Bill Cassidy (R-LA) and Mark Warner (D-VA) are seeking comments on a draft bill to exempt performance-based drug-reimbursement contracts from the Medicaid best price rule, anti-kickback law and the so-called Stark law against doctor self-referrals, the senators announced Tuesday (Jan. 29). They are seeking input from stakeholders before officially introducing the bill. While the Trump administration and brand-drug industry support outcomes-based contracts, some are skeptical that the practice would have a meaningful impact on prescription drug prices. “We are...